Notch signaling in gastrointestinal tract (Review)

International Journal of Oncology

Volumn 30, Issue 1, 2007, Pages 247-251

  Katoh, Masuko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Bioinformatics; Carcinogenesis; FGF; Integrome network; Morphogenesis; Notch; Stem cells; Theoretical biology; WNT

Indexed keywords

NOTCH RECEPTOR;

GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 34748828940     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.1.247     Document Type: Review

References (60)

1. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
2. Radtke F and Raj K: The role of Notch in tumorigenesis: oncogene or tumor suppressor? Nat Rev Cancer 3: 765-767, 2003.
3. Lai EC: Notch signaling: control of cell communication and cell fate. Development 131: 965-973, 2004.
4. Li JL and Harris AL: Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 8: 1-3, 2005.
5. Androutsellis-Theotokis A, Leker RR, Soldner F, et al: Notch signaling regulates stem cell numbers in vitro and in vivo. Nature 442: 823-826, 2006.
6. Leong KG and Karsan A: Recent insight into the role of Notch signaling in tumorigenesis. Blood 107: 2223-2233, 2006.
7. Gray GE, Mann RS, Mitsiadis E, et al: Human ligands of the Notch receptor. Am J Pathol 154: 785-794, 1999.
8. Lindsell CE, Shawber CJ, Boulter J, et al: Jagged: a mammalian ligand that activates Notch1. Cell 80: 909-917, 1995.
9. Luo B, Aster JC, Hasserjian RP, et al: Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol 17: 6057-6067, 1997.
10. Katoh M and Katoh M: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 17: 681-685, 2006.
11. Eiraku M, Hirata Y, Takeshima H, et al: Delta/notch-like EGF-related receptor. J Biol Chem 277: 25400-25407, 2002.
12. Hu QD, Ang BT, Karsak M, et al: F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115: 163-175, 2003.
13. Cui XY, Hu QD, Tekaya M, et al: NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol Chem 279: 25858-25865, 2004.
14. Ellisen LW, Bird J, West DC, et al: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661, 1991.
15. Larsson C, Lardelli M, White I, et al: The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation. Genomics 24: 253-258, 1994.
16. Matsunami N, Hamaguchi Y, Yamamoto Y, et al: A protein binding to the Jκ recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature 342: 934-937, 1989.
17. Wu L, Sun T, Kobayashi K, et al: Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 22: 7688-7700, 2002.
18. Iso T, Kedes L and Hamamori Y: HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255, 2003.
19. Katoh M and Katoh M: Identification and characterization of human HES2, HES3, and HES5 genes in silico. Int J Oncol 25: 529-534, 2004.
20. Katoh M and Katoh M: Identification and characterization of human HESL, rat Hesl and rainbow trout hesl genes in silico. Int J Mol Med 14: 747-751, 2004.
21. Shin HM, Minter LM, Cho OH, et al: Notch1 augments NF-κB activity by facilitating its nuclear retentian. EMBO J 25: 129-138, 2006.
22. Le Borgne R and Schweisguth F: Unequal segregation of Neuralized biases Notch activation during asymmetric cell division. Dev Cell 5: 139-148, 2003.
23. Itoh M, Kim CH, Palardy G, et al: Mindbomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell 4: 67-82, 2003.
24. Koo BK, Yoon KJ, Yoo KW, et al: Mind bomb-2 is an E3 ligase for Notch ligand. J Biol Chem 280: 22335-22342, 2005.
25. Johnston SH, Rauskolb C, Wilson R, et al: A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 124: 2245-2254, 1997.
26. Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995.
27. Wong WT, Schumacher C, Salcini AE, et al: A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution. Proc Natl Acad Sci USA 92: 9530-9534, 1995.
28. Katoh M and Katoh M: NUMB is a break of WNT-Notch signaling cycle. Int J Mol Med 18: 517-521, 2006.
29. Good P, Yoda A, Sakakibara S, et al: The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/ Nrp-1. Genomics 52: 382-384, 1998.
30. Gupta-Rossi N, Le Bail O, Gonen H, et al: Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 276: 34371-34378, 2001.
31. Katoh M: WNT and FGF gene clusters. Int J Oncol 21: 1269-1273, 2002.
32. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD and Serup P: Expression of WNT, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr 11: 141-147, 2003.
33. Garciadiego-Cazares D, Rosales C, Katoh M and Chimal-Monroy J: Coordination of chondrocyte differentiation and joint formation by α5β1 integrin in the developing appendicular skeleton. Development 131: 4735-4742, 2004.
34. Van den Brink GR, Bleuming SA, Hardwick JC, et al: Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 36: 277-282, 2004.
35. Katoh M and Katoh M: Comparative genomics on FGF8, FGF17, and FGF18 orthologs. Int J Mol Med 16: 493-496, 2005.
36. Katoh M and Katoh M: Comparative genomics on FGF20 orthologs. Oncol Rep 14: 287-290, 2005.
37. Katoh Y and Katoh M: Hedgehog signaling in gastric cancer. Cancer Biol Ther 4: 1050-1054, 2005.
38. Radtke F, Clevers H and Riccio O: From gut homoestasis to cancer. Curr Mol Med 6: 275-289, 2006.
39. Katoh Y and Katoh M: WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 17: 171-175, 2006.
40. Katoh Y and Katoh M: Comparative genomics on HHIP family orthologs. Int J Mol Med 17: 391-395, 2006.
41. Katoh Y and Katoh M: FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells. Int J Mol Med 17: 529-532, 2006.
42. Katoh M and Katoh M: Cross-talk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064, 2006.
43. Katoh M: WNT2B: comparative integromics and clinical application. Int J Mol Med 16: 1103-1108, 2005.
44. Katoh M: Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 27: 1677-1683, 2005.
45. Swain RK, Katoh M, Medina A and Steinbeisser H: Xenopus frizzled-4S, a splicing variant of Xfz4, is a context-dependent activator and inhibitor of Wnt/β-catenin signaling. Cell Commun Signal 3: 12, 2005.
46. Sander GR and Powell BC: Expression of notch receptors and ligands in the adult gut. J Histochem Cytochem 52: 509-516, 2004.
47. Thelu J, Rossio P and Favier B: Notch signaling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2: 7, 2002.
48. Sekine A, Akiyama Y, Yanagihara K, et al: Hath1 up-regulates gastric mucin gene expression in gastric cells. Biochem Biophys Res Commun 344: 1166-1171, 2006.
49. Leow CC, Romero MS, Ross S, et al: Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 64: 6050-6057, 2004.
50. Fan X, Mikolaenko I, Elhassan I, et al: Notch1 and Notch2 have opposite effects on embryonal brain tumors. Cancer Res 64: 7787-7793, 2004.
51. Dang TP, Gazdar AF, Virmani AK, et al: Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 92: 1355-1357, 2000.
52. Park JT, Li M, Nakayama K, et al: Notch3 gene amplification in ovarian cancer. Cancer Res 66: 6312-6318, 2006.
53. Reedijk M, Odorcic S, Chang L, et al: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537, 2005.
54. Pece S, Serresi M, Santolini E, et al: Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167: 215-221, 2004.
55. Proweller A, Tu L, Lepore JJ, et al: Impaired Notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 66: 7438-7444, 2006.
56. Snijders AM, Schmidt BL, Fridlyand J, et al: Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242, 2005.
57. Leethanakul C, Patel V, Gillespie J, et al: Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224, 2000.
58. Katoh M: Bioinformatics for cancer management in the postgenome era. Technol Cancer Res Treat 5: 169-176, 2006.
59. Siemers ER, Quinn JF, Kaye J, et al: Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology 66: 602-604, 2006.
60. Hyde LA, McHugh NA, Chen J, et al: Studies to investigate the in vivo therapeutic window of the γ-secretase inhibitor LY411, 575 in the CRND8 mouse. J Pharmacol Exp Ther (Epub ahead of print).